PharmaKorell
PharmaKorell is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Phase 2a, open-label, randomized, controlled, multi-center, proof of concept study, to assess the efficacy, safety, and tolerability of VS-01 on top of standard of care, compared to standard of care alone, in adult patients with acute-on-chronic liver failure (ACLF)
Sponsor Versantis AG
- Start (EU)
- Latest update
- Estimated end
A Randomized, Multi-Center, Double-Blind, Phase III Study Evaluating the Efficacy and Safety of Hetrombopag Olamine Tablets vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia
Sponsor Jiangsu Hengrui Pharmaceuticals Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for PharmaKorell?
The 2026-10-09 snapshot links PharmaKorell to 2 distinct CTIS trials. Recorded services include IMP batch release, Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for PharmaKorell?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to PharmaKorell conducted?
The linked trials record locations in 9 countries, including Spain, France, Belgium, Bulgaria, Germany. These are trial locations, not confirmed office locations or countries where PharmaKorell delivered services.
What can this page tell me about PharmaKorell's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under PharmaKorell. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- PharmaKorell GmbH